StockCIK 1650648
4D Molecular Therapeutics, Inc. (FDMT): Insider Trades and Fund Holdings
In the past 12 months, 4D Molecular Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 8 sales worth $2.74M; 8 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$2.74MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 20, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 20 | Scott BizilyGeneral Counsel | ▼ SELL10b5-1 | $21K |
| Oct 7 | David KirnSee Remarks | ▼ SELL10b5-1 | $754K |
| Sep 22 | Scott BizilyGeneral Counsel | ▼ SELL10b5-1 | $22K |
| Sep 16 | David KirnSee Remarks | ▼ SELL10b5-1 | $811K |
| Sep 3 | Scott BizilyGeneral Counsel | ▼ SELL10b5-1 | $8K |
| Aug 21 | David KirnSee Remarks | ▼ SELL10b5-1 | $1.09M |
| Aug 17 | Scott BizilyGeneral Counsel | ▼ SELL10b5-1 | $20K |
| Aug 17 | Scott BizilyGeneral Counsel | ▼ SELL10b5-1 | $20K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Scott Bizily | General Counsel | 0 | $0 | 5 | $91K |
| David Kirn | See Remarks | 0 | $0 | 3 | $2.65M |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report FDMT
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 614,573 | $8.17M | ▲ +6.3% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →